{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:21:31Z","timestamp":1793726491296,"version":"4.6.1"},"reference-count":222,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["CRG\/2021\/001009"],"award-info":[{"award-number":["CRG\/2021\/001009"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mutation Research - Reviews in Mutation Research"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.mrrev.2024.108518","type":"journal-article","created":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T13:29:16Z","timestamp":1730554156000},"page":"108518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Unraveling the multifaceted insights into amyotrophic lateral sclerosis: Genetic underpinnings, pathogenesis, and therapeutic horizons"],"prefix":"10.1016","volume":"794","author":[{"given":"Ramaish","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuber","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0034-835X","authenticated-orcid":false,"given":"Sidharth","family":"Mehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghanshyam","family":"Das Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Acharan S.","family":"Narula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.mrrev.2024.108518_bib1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/21646821.2015.1075181","article-title":"Amyotrophic lateral sclerosis (ALS) and related motor neuron diseases: an overview","volume":"55","author":"Morris","year":"2015","journal-title":"Neurodiagnostic J."},{"key":"10.1016\/j.mrrev.2024.108518_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120156","article-title":"The panoramic view of amyotrophic lateral sclerosis: A fatal intricate neurological disorder","volume":"288","author":"Dhasmana","year":"2022","journal-title":"Life Sci."},{"issue":"24-25","key":"10.1016\/j.mrrev.2024.108518_bib3","first-page":"1613","article-title":"Amyotrophic lateral sclerosis (ALS)-diagnosis, course of disease and treatment options","volume":"146","author":"Meyer","year":"2021","journal-title":"Dtsch. Med. Wochenschr."},{"issue":"7","key":"10.1016\/j.mrrev.2024.108518_bib4","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1212\/WNL.59.7.1077","article-title":"The overlap of amyotrophic lateral sclerosis and frontotemporal dementia","volume":"59","author":"Lomen-Hoerth","year":"2002","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.mrrev.2024.108518_bib5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4103\/1673-5374.244783","article-title":"Amyotrophic lateral sclerosis: a complex syndrome that needs an integrated research approach","volume":"14","author":"Riancho","year":"2019","journal-title":"Neural Regen. Res."},{"issue":"03","key":"10.1016\/j.mrrev.2024.108518_bib6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4103\/jnrp.jnrp_8_18","article-title":"The profile of amyotrophic lateral sclerosis in natives of Western Himalayas: hospital-based cohort study","volume":"9","author":"Sondhi","year":"2018","journal-title":"J. Neurosci. Rural Pract."},{"issue":"10","key":"10.1016\/j.mrrev.2024.108518_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026449","article-title":"Early life risk factors of motor, cognitive and language development: a pooled analysis of studies from low\/middle-income countries","volume":"9","author":"Sania","year":"2019","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.mrrev.2024.108518_bib8","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3390\/antiox3040770","article-title":"Role of oxidative stress in HIV-1-associated neurocognitive disorder and protection by gene delivery of antioxidant enzymes","volume":"3","author":"Louboutin","year":"2014","journal-title":"Antioxidants"},{"issue":"1-2","key":"10.1016\/j.mrrev.2024.108518_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/08830180490265538","article-title":"T-cell and neuronal apoptosis in HIV infection: implications for therapeutic intervention","volume":"23","author":"R\u00e9gulier","year":"2004","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.mrrev.2024.108518_bib10","first-page":"1","article-title":"A novel supplement attenuates oxidative stress-induced TDP-43-related pathogenesis in TDP-43-expressed cells","volume":"2021","author":"Yang","year":"2021","journal-title":"Evid. -Based Complement. Altern. Med."},{"issue":"2","key":"10.1016\/j.mrrev.2024.108518_bib11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3390\/antiox11020303","article-title":"Identification of regulatory factors and prognostic markers in amyotrophic lateral sclerosis","volume":"11","author":"Sun","year":"2022","journal-title":"Antioxidants"},{"issue":"9","key":"10.1016\/j.mrrev.2024.108518_bib12","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.molmed.2016.07.005","article-title":"Common molecular pathways in amyotrophic lateral sclerosis and frontotemporal dementia","volume":"22","author":"Weishaupt","year":"2016","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.mrrev.2024.108518_bib13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fnins.2020.00042","article-title":"The overlapping genetics of amyotrophic lateral sclerosis and frontotemporal dementia","volume":"14","author":"Abramzon","year":"2020","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.mrrev.2024.108518_bib14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s10038-022-01055-8","article-title":"Genetics of amyotrophic lateral sclerosis: seeking therapeutic targets in the era of gene therapy","volume":"68","author":"Suzuki","year":"2023","journal-title":"J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.mrrev.2024.108518_bib15","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/mgg3.360","article-title":"Patients with sporadic and familial amyotrophic lateral sclerosis found value in genetic testing","volume":"6","author":"Wagner","year":"2018","journal-title":"Mol. Genet. Genom. Med."},{"issue":"2","key":"10.1016\/j.mrrev.2024.108518_bib16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/jnnp-2021-327520","article-title":"De novo mutations in SOD1 are a cause of ALS","volume":"93","author":"M\u00fcller","year":"2022","journal-title":"J. Neurol., Neurosurg. Psychiatry"},{"issue":"12","key":"10.1016\/j.mrrev.2024.108518_bib17","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/nn.3566","article-title":"The mouse C9ORF72 ortholog is enriched in neurons known to degenerate in ALS and FTD","volume":"16","author":"Suzuki","year":"2013","journal-title":"Nat. Neurosci."},{"issue":"383","key":"10.1016\/j.mrrev.2024.108518_bib18","doi-asserted-by":"crossref","first-page":"eaai7866","DOI":"10.1126\/scitranslmed.aai7866","article-title":"Poly (GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis","volume":"9","author":"Gendron","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"15","key":"10.1016\/j.mrrev.2024.108518_bib19","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.15252\/embj.201694401","article-title":"The C9orf72 protein interacts with Rab1a and the ULK 1 complex to regulate initiation of autophagy","volume":"35","author":"Webster","year":"2016","journal-title":"EMBO J."},{"key":"10.1016\/j.mrrev.2024.108518_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2023.1086895","article-title":"Autophagy and neurodegeneration: Unraveling the role of C9ORF72 in the regulation of autophagy and its relationship to ALS-FTD pathology","volume":"17","author":"Diab","year":"2023","journal-title":"Front. Cell. Neurosci."},{"issue":"9","key":"10.1016\/j.mrrev.2024.108518_bib21","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/nn.4604","article-title":"C9orf72 expansion disrupts ATM-mediated chromosomal break repair","volume":"20","author":"Walker","year":"2017","journal-title":"Nat. Neurosci."},{"issue":"4","key":"10.1016\/j.mrrev.2024.108518_bib22","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/jnnp-2012-302272","article-title":"Japanese amyotrophic lateral sclerosis patients with GGGGCC hexanucleotide repeat expansion in C9ORF72","volume":"84","author":"Konno","year":"2013","journal-title":"J. Neurol., Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.mrrev.2024.108518_bib23","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.neurobiolaging.2013.11.034","article-title":"Polymerase chain reaction and Southern blot-based analysis of the C9orf72 hexanucleotide repeat in different motor neuron diseases","volume":"35","author":"H\u00fcbers","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mrrev.2024.108518_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.661447","article-title":"C9ORF72: what it is, what it does, and why it matters","volume":"15","author":"Smeyers","year":"2021","journal-title":"Front. Cell. Neurosci."},{"issue":"9","key":"10.1016\/j.mrrev.2024.108518_bib25","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1093\/brain\/awac165","article-title":"Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cord","volume":"145","author":"Trist","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.mrrev.2024.108518_bib26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neurobiolaging.2018.08.014","article-title":"A novel p. Ser108LeufsTer15 SOD1 mutation leading to the formation of a premature stop codon in an apparently sporadic ALS patient: insights into the underlying pathomechanisms","volume":"72","author":"Canosa","year":"2018","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.mrrev.2024.108518_bib27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41598-021-03891-8","article-title":"SOD1 mutations associated with amyotrophic lateral sclerosis analysis of variant severity","volume":"12","author":"Berdy\u0144ski","year":"2022","journal-title":"Sci. Rep."},{"issue":"5-6","key":"10.1016\/j.mrrev.2024.108518_bib28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/21678421.2017.1301481","article-title":"Comprehensive analysis to explain reduced or increased SOD1 enzymatic activity in ALS patients and their relatives","volume":"18","author":"Keskin","year":"2017","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"issue":"5","key":"10.1016\/j.mrrev.2024.108518_bib29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1474-4422(08)70071-1","article-title":"TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis","volume":"7","author":"Van Deerlin","year":"2008","journal-title":"Lancet Neurol."},{"issue":"18","key":"10.1016\/j.mrrev.2024.108518_bib30","doi-asserted-by":"crossref","first-page":"6000","DOI":"10.1093\/nar\/gki897","article-title":"Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene","volume":"33","author":"Mercado","year":"2005","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.mrrev.2024.108518_bib31","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1001\/archneur.64.10.1388","article-title":"TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: protein misfolding diseases without amyloidosis","volume":"64","author":"Neumann","year":"2007","journal-title":"Arch. Neurol."},{"issue":"5870","key":"10.1016\/j.mrrev.2024.108518_bib32","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.1154584","article-title":"TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis","volume":"319","author":"Sreedharan","year":"2008","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.mrrev.2024.108518_bib33","doi-asserted-by":"crossref","first-page":"12508","DOI":"10.3390\/ijms232012508","article-title":"Molecular Dissection of TDP-43 as a Leading Cause of ALS\/FTLD","volume":"23","author":"Tamaki","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.mrrev.2024.108518_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013250","article-title":"Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue","volume":"5","author":"Liu-Yesucevitz","year":"2010","journal-title":"PloS One"},{"issue":"15","key":"10.1016\/j.mrrev.2024.108518_bib35","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1212\/WNL.0b013e3181bbff05","article-title":"Analysis of FUS gene mutation in familial amyotrophic lateral sclerosis within an Italian cohort","volume":"73","author":"Ticozzi","year":"2009","journal-title":"Neurology"},{"issue":"5918","key":"10.1016\/j.mrrev.2024.108518_bib36","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.1165942","article-title":"Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6","volume":"323","author":"Vance","year":"2009","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.mrrev.2024.108518_bib37","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.neurobiolaging.2009.12.020","article-title":"FUS mutations in sporadic amyotrophic lateral sclerosis","volume":"32","author":"Lai","year":"2011","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.mrrev.2024.108518_bib38","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/jmg.2009.071027","article-title":"Mutations of FUS gene in sporadic amyotrophic lateral sclerosis","volume":"47","author":"Corrado","year":"2010","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.mrrev.2024.108518_bib39","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.neurobiolaging.2015.09.013","article-title":"Replication study of MATR3 in familial and sporadic amyotrophic lateral sclerosis","volume":"37","author":"Leblond","year":"2016","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.mrrev.2024.108518_bib40","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nn.3688","article-title":"Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis","volume":"17","author":"Johnson","year":"2014","journal-title":"Nat. Neurosci."},{"issue":"12","key":"10.1016\/j.mrrev.2024.108518_bib41","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awv175","article-title":"Analysis of the CHCHD10 gene in patients with frontotemporal dementia and amyotrophic lateral sclerosis from Spain","volume":"138","author":"Dols-Icardo","year":"2015","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.mrrev.2024.108518_bib42","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1038\/ncomms15558","article-title":"Loss of function CHCHD10 mutations in cytoplasmic TDP-43 accumulation and synaptic integrity","volume":"8","author":"Woo","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mrrev.2024.108518_bib43","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.neurobiolaging.2016.12.008","article-title":"Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients","volume":"51","author":"Perrone","year":"2017","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.mrrev.2024.108518_bib44","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1091\/mbc.e13-07-0387","article-title":"Effects of tubulin acetylation and tubulin acetyltransferase binding on microtubule structure","volume":"25","author":"Howes","year":"2014","journal-title":"Mol. Biol. Cell"},{"issue":"4","key":"10.1016\/j.mrrev.2024.108518_bib45","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ana.23832","article-title":"Mutations in the autoregulatory domain of \u03b2-tubulin 4a cause hereditary dystonia","volume":"73","author":"Hersheson","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mrrev.2024.108518_bib46","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neurobiolaging.2015.12.022","article-title":"Mutational analysis of TBK1 in Taiwanese patients with amyotrophic lateral sclerosis","volume":"40","author":"Tsai","year":"2016","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.mrrev.2024.108518_bib47","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nn.4000","article-title":"Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia","volume":"18","author":"Freischmidt","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.mrrev.2024.108518_bib48","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.neurobiolaging.2018.06.015","article-title":"ALS-associated missense and nonsense TBK1 mutations can both cause loss of kinase function","volume":"71","author":"de Majo","year":"2018","journal-title":"Neurobiol. Aging"},{"issue":"6229","key":"10.1016\/j.mrrev.2024.108518_bib49","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1126\/science.aaa3650","article-title":"Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways","volume":"347","author":"Cirulli","year":"2015","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.mrrev.2024.108518_bib50","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/jnnp-2017-316174","article-title":"TBK1 mutations in Italian patients with amyotrophic lateral sclerosis: genetic and functional characterisation","volume":"88","author":"Pozzi","year":"2017","journal-title":"J. Neurol., Neurosurg. Psychiatry"},{"issue":"6","key":"10.1016\/j.mrrev.2024.108518_bib51","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.neuron.2018.02.027","article-title":"Genome-wide analyses identify KIF5A as a novel ALS gene","volume":"97","author":"Nicolas","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.mrrev.2024.108518_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-5-52","article-title":"A hereditary spastic paraplegia mutation in kinesin-1A\/KIF5A disrupts neurofilament transport","volume":"5","author":"Wang","year":"2010","journal-title":"Mol. Neurodegener."},{"issue":"6","key":"10.1016\/j.mrrev.2024.108518_bib53","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/gtc.12936","article-title":"An ALS-associated KIF5A mutant forms oligomers and aggregates and induces neuronal toxicity","volume":"27","author":"Nakano","year":"2022","journal-title":"Genes Cells"},{"issue":"1","key":"10.1016\/j.mrrev.2024.108518_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110598","article-title":"ALS-associated KIF5A mutations abolish autoinhibition resulting in a toxic gain of function","volume":"39","author":"Baron","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.mrrev.2024.108518_bib55","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00439-006-0237-7","article-title":"Sequencing EVC and EVC2 identifies mutations in two-thirds of Ellis\u2013van Creveld syndrome patients","volume":"120","author":"Tompson","year":"2007","journal-title":"Hum. Genet."},{"issue":"12","key":"10.1016\/j.mrrev.2024.108518_bib56","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.1074\/jbc.M808064200","article-title":"Potentiation of amyotrophic lateral sclerosis (ALS)-associated TDP-43 aggregation by the proteasome-targeting factor, ubiquilin 1","volume":"284","author":"Kim","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"1-3","key":"10.1016\/j.mrrev.2024.108518_bib57","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.febslet.2004.04.031","article-title":"Ubiquilin interacts with ubiquitylated proteins and proteasome through its ubiquitin-associated and ubiquitin-like domains","volume":"566","author":"Ko","year":"2004","journal-title":"FEBS Lett."},{"issue":"7363","key":"10.1016\/j.mrrev.2024.108518_bib58","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nature10353","article-title":"Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS\/dementia","volume":"477","author":"Deng","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.mrrev.2024.108518_bib59","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.biocel.2014.02.018","article-title":"Ubiquilin 2: A component of the ubiquitin\u2013proteasome system with an emerging role in neurodegeneration","volume":"50","author":"Zhang","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.mrrev.2024.108518_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-019-0758-7","article-title":"Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia","volume":"7","author":"Renaud","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"issue":"9","key":"10.1016\/j.mrrev.2024.108518_bib61","doi-asserted-by":"crossref","first-page":"18999","DOI":"10.3390\/ijms140918999","article-title":"hnRNP A1: the Swiss army knife of gene expression","volume":"14","author":"Jean-Philippe","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"5796","key":"10.1016\/j.mrrev.2024.108518_bib62","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.mrrev.2024.108518_bib63","first-page":"658","article-title":"Multisystem proteinopathy: intersecting genetics in muscle, bone, and brain degeneration","author":"Taylor","year":"2015","journal-title":"AAN Enterp."},{"issue":"1","key":"10.1016\/j.mrrev.2024.108518_bib64","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cell.2015.09.015","article-title":"Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization","volume":"163","author":"Molliex","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.mrrev.2024.108518_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00326","article-title":"Linking hnRNP function to ALS and FTD pathology","volume":"12","author":"Purice","year":"2018","journal-title":"Front. Neurosci."},{"issue":"14","key":"10.1016\/j.mrrev.2024.108518_bib66","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.148363","article-title":"Characterization of HNRNPA1 mutations defines diversity in pathogenic mechanisms and clinical presentation","volume":"6","author":"Beijer","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.mrrev.2024.108518_bib67","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neurobiolaging.2017.08.030","article-title":"Molecular epidemiological study of familial amyotrophic lateral sclerosis in Japanese population by whole-exome sequencing and identification of novel HNRNPA1 mutation","volume":"61","author":"Naruse","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mrrev.2024.108518_bib68","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.preteyeres.2016.08.002","article-title":"Significance of optineurin mutations in glaucoma and other diseases","volume":"55","author":"Minegishi","year":"2016","journal-title":"Prog. Retin. Eye Res."},{"issue":"42","key":"10.1016\/j.mrrev.2024.108518_bib69","doi-asserted-by":"crossref","first-page":"E4439","DOI":"10.1073\/pnas.1405752111","article-title":"Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation","volume":"111","author":"Wong","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"11","key":"10.1016\/j.mrrev.2024.108518_bib70","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1136\/jnnp.2011.242313","article-title":"Novel optineurin mutations in patients with familial and sporadic amyotrophic lateral sclerosis","volume":"82","author":"Del","year":"2011","journal-title":"J. Neurol., Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.mrrev.2024.108518_bib71","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11253","article-title":"CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia","volume":"7","author":"Williams","year":"2016","journal-title":"Nat. Commun."},{"issue":"7302","key":"10.1016\/j.mrrev.2024.108518_bib72","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nature09140","article-title":"SCFCyclin F controls centrosome homeostasis and mitotic fidelity through CP110 degradation","volume":"466","author":"D\u2019Angiolella","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.mrrev.2024.108518_bib73","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00018-017-2632-8","article-title":"Pathogenic mutation in the ALS\/FTD gene, CCNF, causes elevated Lys48-linked ubiquitylation and defective autophagy","volume":"75","author":"Lee","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"issue":"11","key":"10.1016\/j.mrrev.2024.108518_bib74","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/hmg\/ddab073","article-title":"ALS\/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ","volume":"30","author":"Rayner","year":"2021","journal-title":"Hum. Mol. Genet."},{"issue":"14","key":"10.1016\/j.mrrev.2024.108518_bib75","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1093\/hmg\/ddx136","article-title":"Expression of ALS\/FTD-linked mutant CCNF in zebrafish leads to increased cell death in the spinal cord and an aberrant motor phenotype","volume":"26","author":"Hogan","year":"2017","journal-title":"Hum. Mol. Genet."},{"issue":"7","key":"10.1016\/j.mrrev.2024.108518_bib76","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1007\/s12035-023-03380-1","article-title":"Genetic and phenotypic spectrum of amyotrophic lateral sclerosis patients with CCNF variants from a large Chinese cohort","volume":"60","author":"Zhao","year":"2023","journal-title":"Mol. Neurobiol."},{"issue":"9","key":"10.1016\/j.mrrev.2024.108518_bib77","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia","volume":"134","author":"Rascovsky","year":"2011","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.mrrev.2024.108518_bib78","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.170058","article-title":"Casein kinase II phosphorylation of cyclin F at serine 621 regulates the Lys48-ubiquitylation E3 ligase activity of the SCF (cyclin F) complex","volume":"7","author":"Lee","year":"2017","journal-title":"Open Biol."},{"issue":"9","key":"10.1016\/j.mrrev.2024.108518_bib79","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.celrep.2019.02.006","article-title":"Mutations in the glycosyltransferase domain of GLT8D1 are associated with familial amyotrophic lateral sclerosis","volume":"26","author":"Cooper-Knock","year":"2019","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.mrrev.2024.108518_bib80","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1093\/brain\/awz358","article-title":"Disrupted glycosylation of lipids and proteins is a cause of neurodegeneration","volume":"143","author":"Moll","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.mrrev.2024.108518_bib81","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.neurobiolaging.2020.10.017","article-title":"Mutation screening and burden analysis of GLT8D1 in Chinese patients with amyotrophic lateral sclerosis","volume":"101","author":"Cao","year":"2021","journal-title":"Neurobiol. Aging"},{"issue":"6","key":"10.1016\/j.mrrev.2024.108518_bib82","article-title":"Genetic and Functional Analysis of Glycosyltransferase 8 Domain\u2013Containing Protein 1 in Taiwanese Patients With Amyotrophic Lateral Sclerosis","volume":"7","author":"Tsai","year":"2021","journal-title":"Neurol.: Genet."},{"issue":"4","key":"10.1016\/j.mrrev.2024.108518_bib83","first-page":"512","article-title":"1-Deoxysphingolipids","volume":"1864","author":"Lone","year":"2019","journal-title":"Biochim. Et. Biophys. Acta (BBA)-Mol. Cell Biol. Lipids"},{"issue":"15","key":"10.1016\/j.mrrev.2024.108518_bib84","doi-asserted-by":"crossref","first-page":"11178","DOI":"10.1074\/jbc.M109.092973","article-title":"Hereditary Sensory Neuropathy Type 1 Is Caused by the Accumulation of Two Neurotoxic Sphingolipids*\u2666","volume":"285","author":"Penno","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.mrrev.2024.108518_bib85","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/s41591-021-01346-1","article-title":"Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis","volume":"27","author":"Mohassel","year":"2021","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.mrrev.2024.108518_bib86","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1001\/jamaneurol.2021.2598","article-title":"Association of variants in the SPTLC1 gene with juvenile amyotrophic lateral sclerosis","volume":"78","author":"Johnson","year":"2021","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.mrrev.2024.108518_bib87","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40246-023-00479-3","article-title":"Mutation screening of SPTLC1 and SPTLC2 in amyotrophic lateral sclerosis","volume":"17","author":"Li","year":"2023","journal-title":"Hum. Genom."},{"key":"10.1016\/j.mrrev.2024.108518_bib88","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.neurobiolaging.2021.04.026","article-title":"Validation of the pathogenic role of rare DNAJC7 variants in Chinese patients with amyotrophic lateral sclerosis","volume":"106","author":"He","year":"2021","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.mrrev.2024.108518_bib89","article-title":"Rapid progressive ALS in a patient with a DNAJC7 loss-of-function mutation","volume":"6","author":"Jih","year":"2020","journal-title":"Neurol.: Genet."},{"issue":"5","key":"10.1016\/j.mrrev.2024.108518_bib90","doi-asserted-by":"crossref","first-page":"a030718","DOI":"10.1101\/cshperspect.a030718","article-title":"TIA-1 is a functional prion-like protein","volume":"9","author":"Rayman","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"3","key":"10.1016\/j.mrrev.2024.108518_bib91","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.tibs.2007.12.003","article-title":"Stress granules: the Tao of RNA triage","volume":"33","author":"Anderson","year":"2008","journal-title":"Trends Biochem. Sci."},{"issue":"4","key":"10.1016\/j.mrrev.2024.108518_bib92","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.neuron.2017.07.025","article-title":"TIA1 mutations in amyotrophic lateral sclerosis and frontotemporal dementia promote phase separation and alter stress granule dynamics","volume":"95","author":"Mackenzie","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.mrrev.2024.108518_bib93","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cca.2014.01.031","article-title":"Annexin A11 in disease","volume":"431","author":"Wang","year":"2014","journal-title":"Clin. Chim. Acta"},{"issue":"10","key":"10.1016\/j.mrrev.2024.108518_bib94","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.febslet.2008.03.036","article-title":"The mammalian Nek1 kinase is involved in primary cilium formation","volume":"582","author":"Shalom","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.mrrev.2024.108518_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1741-7007-9-54","article-title":"Identification and characterization of a set of conserved and new regulators of cytoskeletal organization, cell morphology and migration","volume":"9","author":"Bai","year":"2011","journal-title":"BMC Biol."},{"issue":"11","key":"10.1016\/j.mrrev.2024.108518_bib96","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nrm2278","article-title":"When cilia go bad: cilia defects and ciliopathies","volume":"8","author":"Fliegauf","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"10","key":"10.1016\/j.mrrev.2024.108518_bib97","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/abbs\/gmv076","article-title":"The NEK1 interactor, C21ORF2, is required for efficient DNA damage repair","volume":"47","author":"Fang","year":"2015","journal-title":"Acta Biochim. Et. Biophys. Sin."},{"issue":"8","key":"10.1016\/j.mrrev.2024.108518_bib98","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/ncb3201","article-title":"An siRNA-based functional genomics screen for the identification of regulators of ciliogenesis and ciliopathy genes","volume":"17","author":"Wheway","year":"2015","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.mrrev.2024.108518_bib99","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuron.2014.06.007","article-title":"Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases","volume":"83","author":"Mei","year":"2014","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.mrrev.2024.108518_bib100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nn.2231","article-title":"Bidirectional modulation of synaptic functions by Eph\/ephrin signaling","volume":"12","author":"Klein","year":"2009","journal-title":"Nat. Neurosci."},{"issue":"9","key":"10.1016\/j.mrrev.2024.108518_bib101","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/nm.2901","article-title":"EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans","volume":"18","author":"Van Hoecke","year":"2012","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.mrrev.2024.108518_bib102","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13073-020-00742-5","article-title":"Polygenic risk scores: from research tools to clinical instruments","volume":"12","author":"Lewis","year":"2020","journal-title":"Genome Med."},{"key":"10.1016\/j.mrrev.2024.108518_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.818574","article-title":"Calculating polygenic risk scores (PRS) in UK Biobank: a practical guide for epidemiologists","volume":"13","author":"Collister","year":"2022","journal-title":"Front. Genet."},{"issue":"11","key":"10.1016\/j.mrrev.2024.108518_bib104","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.tig.2021.06.004","article-title":"Genetic prediction of complex traits with polygenic scores: a statistical review","volume":"37","author":"Ma","year":"2021","journal-title":"Trends Genet."},{"issue":"2","key":"10.1016\/j.mrrev.2024.108518_bib105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41588-017-0009-4","article-title":"Multi-trait analysis of genome-wide association summary statistics using MTAG","volume":"50","author":"Turley","year":"2018","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.mrrev.2024.108518_bib106","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1038\/s41467-019-12653-0","article-title":"Improved polygenic prediction by Bayesian multiple regression on summary statistics","volume":"10","author":"Lloyd-Jones","year":"2019","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.mrrev.2024.108518_bib107","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41431-021-00885-y","article-title":"Polygenic risk score analysis for amyotrophic lateral sclerosis leveraging cognitive performance, educational attainment and schizophrenia","volume":"30","author":"Restuadi","year":"2022","journal-title":"Eur. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.mrrev.2024.108518_bib108","article-title":"Cumulative genetic score and C9orf72 repeat status independently contribute to amyotrophic lateral sclerosis risk in 2 case-control studies","volume":"9","author":"Dou","year":"2023","journal-title":"Neurol.: Genet."},{"key":"10.1016\/j.mrrev.2024.108518_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103795","article-title":"Unraveling the complex interplay between genes, environment, and climate in ALS","volume":"75","author":"Vasta","year":"2022","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.mrrev.2024.108518_bib110","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.neuro.2006.11.007","article-title":"A gene\u2013environment study of the paraoxonase 1 gene and pesticides in amyotrophic lateral sclerosis","volume":"28","author":"Morahan","year":"2007","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.mrrev.2024.108518_bib111","first-page":"47","article-title":"Genetics, epigenetics, and pregenetics","author":"Srinivasan","year":"2011","journal-title":"Medknow"},{"issue":"6","key":"10.1016\/j.mrrev.2024.108518_bib112","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1006\/pmed.1996.0117","article-title":"Gene\u2013environment interaction: definitions and study design","volume":"25","author":"Ottman","year":"1996","journal-title":"Prev. Med."},{"issue":"4","key":"10.1016\/j.mrrev.2024.108518_bib113","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/17482960902721634","article-title":"ALS in Italian professional soccer players: the risk is still present and could be soccer-specific","volume":"10","author":"Chio","year":"2009","journal-title":"Amyotroph. Lateral Scler."},{"issue":"5","key":"10.1016\/j.mrrev.2024.108518_bib114","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s00415-009-5419-5","article-title":"Rural environment and risk factors of amyotrophic lateral sclerosis: a case\u2013control study","volume":"257","author":"Furby","year":"2010","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.mrrev.2024.108518_bib115","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.mehy.2013.04.039","article-title":"Cyanobacteria biomagnification and amyotrophic lateral sclerosis","volume":"81","author":"Stipa","year":"2013","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.mrrev.2024.108518_bib116","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00204-016-1913-6","article-title":"C yanotoxins: producing organisms, occurrence, toxicity, mechanism of action and human health toxicological risk evaluation","volume":"91","author":"Buratti","year":"2017","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.mrrev.2024.108518_bib117","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s10654-017-0327-y","article-title":"Meta-analytic evaluation of the association between head injury and risk of amyotrophic lateral sclerosis","volume":"32","author":"Watanabe","year":"2017","journal-title":"Eur. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.mrrev.2024.108518_bib118","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3390\/ijerph17030857","article-title":"Clinical and lifestyle factors and risk of amyotrophic lateral sclerosis: A population-based case-control study","volume":"17","author":"Filippini","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"2","key":"10.1016\/j.mrrev.2024.108518_bib119","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/EDE.0b013e3181632c5d","article-title":"Diet and amyotrophic lateral sclerosis","volume":"19","author":"Morozova","year":"2008","journal-title":"Epidemiology"},{"issue":"1","key":"10.1016\/j.mrrev.2024.108518_bib120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/jnnp-2019-320986","article-title":"Effect modification of the association between total cigarette smoking and ALS risk by intensity, duration and time-since-quitting: Euro-MOTOR","volume":"91","author":"Peters","year":"2020","journal-title":"J. Neurol., Neurosurg. Psychiatry"},{"issue":"11","key":"10.1016\/j.mrrev.2024.108518_bib121","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1136\/jnnp.2009.180232","article-title":"Smoking and the risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"81","author":"Alonso","year":"2010","journal-title":"J. Neurol., Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.mrrev.2024.108518_bib122","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3109\/17482968.2012.700938","article-title":"Season and weather patterns at time of birth in amyotrophic lateral sclerosis","volume":"13","author":"Pamphlett","year":"2012","journal-title":"Amyotroph. Lateral Scler."},{"issue":"12","key":"10.1016\/j.mrrev.2024.108518_bib123","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029354","article-title":"Vitamin D3 deficiency differentially affects functional and disease outcomes in the G93A mouse model of amyotrophic lateral sclerosis","volume":"6","author":"Solomon","year":"2011","journal-title":"PLoS One"},{"issue":"6386","key":"10.1016\/j.mrrev.2024.108518_bib124","doi-asserted-by":"crossref","DOI":"10.1126\/science.aao1729","article-title":"Systematic analysis of complex genetic interactions","volume":"360","author":"Kuzmin","year":"2018","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.mrrev.2024.108518_bib125","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/nrg2452","article-title":"Epistasis\u2014the essential role of gene interactions in the structure and evolution of genetic systems","volume":"9","author":"Phillips","year":"2008","journal-title":"Nat. Rev. Genet."},{"issue":"5","key":"10.1016\/j.mrrev.2024.108518_bib126","doi-asserted-by":"crossref","first-page":"a024125","DOI":"10.1101\/cshperspect.a024125","article-title":"Genetics of amyotrophic lateral sclerosis","volume":"8","author":"Ghasemi","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"7","key":"10.1016\/j.mrrev.2024.108518_bib127","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/jnnp-2012-302219","article-title":"ALS\/FTD phenotype in two Sardinian families carrying both C9ORF72 and TARDBP mutations","volume":"83","author":"Chi\u00f2","year":"2012","journal-title":"J. Neurol., Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.mrrev.2024.108518_bib128","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007279","article-title":"Identity-by-descent analyses for measuring population dynamics and selection in recombining pathogens","volume":"14","author":"Henden","year":"2018","journal-title":"PLoS Genet."},{"issue":"5","key":"10.1016\/j.mrrev.2024.108518_bib129","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3390\/cells12050736","article-title":"Current state and future directions in the diagnosis of amyotrophic lateral sclerosis","volume":"12","author":"Vidovic","year":"2023","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.mrrev.2024.108518_bib130","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S1474-4422(21)00465-8","article-title":"Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis","volume":"21","author":"Goutman","year":"2022","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.mrrev.2024.108518_bib131","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S1474-4422(15)00134-9","article-title":"Progress towards a neuroimaging biomarker for amyotrophic lateral sclerosis","volume":"14","author":"Filippi","year":"2015","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.mrrev.2024.108518_bib132","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/14737175.2018.1463160","article-title":"Neuroimaging in amyotrophic lateral sclerosis: current and emerging uses","volume":"18","author":"Agosta","year":"2018","journal-title":"Expert Rev. Neurother."},{"issue":"10","key":"10.1016\/j.mrrev.2024.108518_bib133","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.acra.2017.04.008","article-title":"Quantitative FLAIR MRI in amyotrophic lateral sclerosis","volume":"24","author":"Fabes","year":"2017","journal-title":"Acad. Radiol."},{"key":"10.1016\/j.mrrev.2024.108518_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2019.116440","article-title":"The motor band sign in ALS: presentations and frequencies in a consecutive series of ALS patients","volume":"406","author":"Roeben","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.mrrev.2024.108518_bib135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00415-013-7144-3","article-title":"Distributed corpus callosum involvement in amyotrophic lateral sclerosis: a deterministic tractography study using q-ball imaging","volume":"261","author":"Caiazzo","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.mrrev.2024.108518_bib136","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1007\/s00415-014-7434-4","article-title":"Central white matter degeneration in bulbar-and limb-onset amyotrophic lateral sclerosis","volume":"261","author":"Cardenas-Blanco","year":"2014","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.mrrev.2024.108518_bib137","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nn.3584","article-title":"State of play in amyotrophic lateral sclerosis genetics","volume":"17","author":"Renton","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.mrrev.2024.108518_bib138","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11910-004-0081-x","article-title":"Genetics and genetic counseling: recommendations for Alzheimer\u2019s disease, frontotemporal dementia, and Creutzfeldt-Jakob disease","volume":"4","author":"Williamson","year":"2004","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"5","key":"10.1016\/j.mrrev.2024.108518_bib139","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nn.4012","article-title":"Exome sequencing uncovers hidden pathways in familial and sporadic ALS","volume":"18","author":"Bettencourt","year":"2015","journal-title":"Nat. Neurosci."},{"issue":"4","key":"10.1016\/j.mrrev.2024.108518_bib140","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3109\/17482968.2011.566618","article-title":"Abnormalities of satellite cells function in amyotrophic lateral sclerosis","volume":"12","author":"Pradat","year":"2011","journal-title":"Amyotroph. Lateral Scler."},{"issue":"12","key":"10.1016\/j.mrrev.2024.108518_bib141","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/glia.22891","article-title":"NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients","volume":"63","author":"Johann","year":"2015","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.mrrev.2024.108518_bib142","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1471-4159.2011.07224.x","article-title":"Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS","volume":"117","author":"Ganesalingam","year":"2011","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.mrrev.2024.108518_bib143","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/jmedgenet-2014-102360","article-title":"A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratories","volume":"51","author":"Akimoto","year":"2014","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.mrrev.2024.108518_bib144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2015.07.004","article-title":"Amyotrophic lateral sclerosis: Current perspectives from basic research to the clinic","volume":"133","author":"Mancuso","year":"2015","journal-title":"Prog. Neurobiol."},{"issue":"6","key":"10.1016\/j.mrrev.2024.108518_bib145","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nrneurol.2015.65","article-title":"FTD and ALS\u2014translating mouse studies into clinical trials","volume":"11","author":"Ittner","year":"2015","journal-title":"Nat. Rev. Neurol."},{"issue":"3","key":"10.1016\/j.mrrev.2024.108518_bib146","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.3390\/ijms23031329","article-title":"Emerging connections between nuclear pore complex homeostasis and ALS","volume":"23","author":"Chandra","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mrrev.2024.108518_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104835","article-title":"Traffic jam at the nuclear pore: all roads lead to nucleocytoplasmic transport defects in ALS\/FTD","volume":"140","author":"Fallini","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.mrrev.2024.108518_bib148","doi-asserted-by":"crossref","DOI":"10.1080\/19491034.2024.2314297","article-title":"Nuclear pore dysfunction and disease: a complex opportunity","volume":"15","author":"Fare","year":"2024","journal-title":"Nucleus"},{"issue":"2","key":"10.1016\/j.mrrev.2024.108518_bib149","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.neuron.2017.07.029","article-title":"Lost in transportation: nucleocytoplasmic transport defects in ALS and other neurodegenerative diseases","volume":"96","author":"Kim","year":"2017","journal-title":"Neuron"},{"issue":"22","key":"10.1016\/j.mrrev.2024.108518_bib150","doi-asserted-by":"crossref","first-page":"12175","DOI":"10.3390\/ijms222212175","article-title":"The role of nucleocytoplasmic transport defects in amyotrophic lateral sclerosis","volume":"22","author":"Vanneste","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.mrrev.2024.108518_bib151","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nrg1428","article-title":"Pharmacogenetics\u2013five decades of therapeutic lessons from genetic diversity","volume":"5","author":"Meyer","year":"2004","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.mrrev.2024.108518_bib152","first-page":"59","article-title":"Dynamic meta-analysis as a therapeutic prediction tool for amyotrophic lateral sclerosis","author":"Mitchell","year":"2012","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.mrrev.2024.108518_bib153","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev-neuro-070918-050501","article-title":"Antisense oligonucleotide therapies for neurodegenerative diseases","volume":"42","author":"Bennett","year":"2019","journal-title":"Annu. Rev. Neurosci."},{"issue":"8","key":"10.1016\/j.mrrev.2024.108518_bib154","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1172\/JCI25424","article-title":"Antisense oligonucleotide therapy for neurodegenerative disease","volume":"116","author":"Smith","year":"2006","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.mrrev.2024.108518_bib155","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1474-4422(13)70061-9","article-title":"A phase I, randomised, first-in-human study of an antisense oligonucleotide directed against SOD1 delivered intrathecally in SOD1-familial ALS patients","volume":"12","author":"Miller","year":"2013","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.mrrev.2024.108518_bib156","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2003715","article-title":"Phase 1\u20132 trial of antisense oligonucleotide tofersen for SOD1 ALS","volume":"383","author":"Miller","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.mrrev.2024.108518_bib157","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1056\/NEJMoa2005056","article-title":"SOD1 suppression with adeno-associated virus and microRNA in familial ALS","volume":"383","author":"Mueller","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"465","key":"10.1016\/j.mrrev.2024.108518_bib158","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau6414","article-title":"Safe and effective superoxide dismutase 1 silencing using artificial microRNA in macaques","volume":"10","author":"Borel","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"9","key":"10.1016\/j.mrrev.2024.108518_bib159","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.ymthe.2017.05.017","article-title":"A new AAV10-U7-mediated gene therapy prolongs survival and restores function in an ALS mouse model","volume":"25","author":"Biferi","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mrrev.2024.108518_bib160","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.omtn.2019.02.001","article-title":"Targeting RNA-mediated toxicity in C9orf72 ALS and\/or FTD by RNAi-based gene therapy","volume":"16","author":"Martier","year":"2019","journal-title":"Mol. Ther. -Nucleic Acids"},{"issue":"8","key":"10.1016\/j.mrrev.2024.108518_bib161","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1074\/jbc.C113.502336","article-title":"TMPyP4 porphyrin distorts RNA G-quadruplex structures of the disease-associated r (GGGGCC) n repeat of the C9orf72 gene and blocks interaction of RNA-binding proteins","volume":"289","author":"Zamiri","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.mrrev.2024.108518_bib162","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.chembiol.2018.10.018","article-title":"The hairpin form of r (G4C2) exp in c9ALS\/FTD is repeat-associated non-ATG translated and a target for bioactive small molecules","volume":"26","author":"Wang","year":"2019","journal-title":"Cell Chem. Biol."},{"issue":"12","key":"10.1016\/j.mrrev.2024.108518_bib163","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1093\/nar\/gkq135","article-title":"Spt4\/5 stimulates transcription elongation through the RNA polymerase clamp coiled-coil motif","volume":"38","author":"Hirtreiter","year":"2010","journal-title":"Nucleic Acids Res."},{"issue":"6300","key":"10.1016\/j.mrrev.2024.108518_bib164","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1126\/science.aaf7791","article-title":"Spt4 selectively regulates the expression of C9orf72 sense and antisense mutant transcripts","volume":"353","author":"Kramer","year":"2016","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.mrrev.2024.108518_bib165","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aar3952","article-title":"In vivo genome editing improves motor function and extends survival in a mouse model of ALS","volume":"3","author":"Gaj","year":"2017","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.mrrev.2024.108518_bib166","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.molcel.2017.09.033","article-title":"Impeding transcription of expanded microsatellite repeats by deactivated Cas9","volume":"68","author":"Pinto","year":"2017","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.mrrev.2024.108518_bib167","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.cell.2017.07.010","article-title":"Elimination of toxic microsatellite repeat expansion RNA by RNA-targeting Cas9","volume":"170","author":"Batra","year":"2017","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.mrrev.2024.108518_bib168","doi-asserted-by":"crossref","first-page":"687","DOI":"10.15252\/emmm.201607054","article-title":"Antibodies inhibit transmission and aggregation of C9orf72 poly-GA dipeptide repeat proteins","volume":"9","author":"Zhou","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.mrrev.2024.108518_bib169","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12192-017-0806-9","article-title":"The small heat shock protein B8 (HSPB8) efficiently removes aggregating species of dipeptides produced in C9ORF72-related neurodegenerative diseases","volume":"23","author":"Cristofani","year":"2018","journal-title":"Cell Stress Chaperon-.-."},{"issue":"5","key":"10.1016\/j.mrrev.2024.108518_bib170","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.neuron.2019.09.003","article-title":"CRISPR-Cas9 screens identify the RNA helicase DDX3X as a repressor of C9ORF72 (GGGGCC) n repeat-associated non-AUG translation","volume":"104","author":"Cheng","year":"2019","journal-title":"Neuron"},{"issue":"7310","key":"10.1016\/j.mrrev.2024.108518_bib171","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature09320","article-title":"Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS","volume":"466","author":"Elden","year":"2010","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.mrrev.2024.108518_bib172","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2018100989","article-title":"Abnormal TDP-43 function impairs activity-dependent BDNF secretion, synaptic plasticity, and cognitive behavior through altered Sortilin splicing","volume":"38","author":"Tann","year":"2019","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.mrrev.2024.108518_bib173","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.stemcr.2017.02.019","article-title":"Genetic correction of SOD1 mutant iPSCs reveals ERK and JNK activated AP1 as a driver of neurodegeneration in amyotrophic lateral sclerosis","volume":"8","author":"Bhinge","year":"2017","journal-title":"Stem Cell Rep."},{"issue":"1","key":"10.1016\/j.mrrev.2024.108518_bib174","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.nmd.2011.08.003","article-title":"P525L FUS mutation is consistently associated with a severe form of juvenile amyotrophic lateral sclerosis","volume":"22","author":"Conte","year":"2012","journal-title":"Neuromuscul. Disord."},{"issue":"1","key":"10.1016\/j.mrrev.2024.108518_bib175","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41591-021-01615-z","article-title":"Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis","volume":"28","author":"Korobeynikov","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.mrrev.2024.108518_bib176","doi-asserted-by":"crossref","DOI":"10.1038\/d41591-019-00013-w","article-title":"Tailored treatment for ALS poised to move ahead","author":"Arnold","year":"2019","journal-title":"Nat. Med."},{"issue":"13","key":"10.1016\/j.mrrev.2024.108518_bib177","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.3390\/cells11132066","article-title":"Gene therapy in amyotrophic lateral sclerosis","volume":"11","author":"Fang","year":"2022","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.mrrev.2024.108518_bib178","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41434-019-0116-1","article-title":"The deletion of mutant SOD1 via CRISPR\/Cas9\/sgRNA prolongs survival in an amyotrophic lateral sclerosis mouse model","volume":"27","author":"Duan","year":"2020","journal-title":"Gene Ther."},{"key":"10.1016\/j.mrrev.2024.108518_bib179","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.686995","article-title":"Potential therapeutic role of HDAC inhibitors in FUS-ALS","volume":"14","author":"Tejido","year":"2021","journal-title":"Front. Mol. Neurosci."},{"issue":"9","key":"10.1016\/j.mrrev.2024.108518_bib180","article-title":"Exploring advancements in the treatment of amyotrophic lateral sclerosis: a comprehensive review of current modalities and future prospects","volume":"15","author":"Hoxhaj","year":"2023","journal-title":"Cureus"},{"issue":"11","key":"10.1016\/j.mrrev.2024.108518_bib181","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3390\/cells12111523","article-title":"Current state and future directions in the therapy of ALS","volume":"12","author":"Tzeplaeff","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.mrrev.2024.108518_bib182","article-title":"Potential of cellular therapy for ALS: current strategies and future prospects","volume":"10","author":"Lin","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.mrrev.2024.108518_bib183","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.otc.2008.09.010","article-title":"Palliative treatment of dysphonia and dysarthria","volume":"42","author":"Cohen","year":"2009","journal-title":"Otolaryngol. Clin. North Am."},{"issue":"10","key":"10.1016\/j.mrrev.2024.108518_bib184","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic lateral sclerosis: a clinical review","volume":"27","author":"Masrori","year":"2020","journal-title":"Eur. J. Neurol."},{"issue":"6","key":"10.1016\/j.mrrev.2024.108518_bib185","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3233\/NRE-2007-22607","article-title":"The role of augmentative communication devices in the medical management of ALS","volume":"22","author":"Brownlee","year":"2007","journal-title":"NeuroRehabilitation"},{"issue":"3","key":"10.1016\/j.mrrev.2024.108518_bib186","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3109\/21678421.2013.774586","article-title":"Speech therapy and communication device: Impact on quality of life and mood in patients with amyotrophic lateral sclerosis (vol 14, pg 20, 2013)","volume":"14","author":"Koerner","year":"2013","journal-title":"Amyotroph. Later. Scler. Frontotemp. Degener."},{"issue":"10","key":"10.1016\/j.mrrev.2024.108518_bib187","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMoa1916945","article-title":"Trial of sodium phenylbutyrate\u2013taurursodiol for amyotrophic lateral sclerosis","volume":"383","author":"Paganoni","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.mrrev.2024.108518_bib188","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s40265-022-01769-1","article-title":"Pharmacotherapy for amyotrophic lateral sclerosis: a review of approved and upcoming agents","volume":"82","author":"Johnson","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.mrrev.2024.108518_bib189","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1054006","article-title":"New developments and opportunities in drugs being trialed for amyotrophic lateral sclerosis from 2020 to 2022","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.mrrev.2024.108518_bib190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-019-1443-y","article-title":"Real world experience of patients with amyotrophic lateral sclerosis (ALS) in the treatment of spasticity using tetrahydrocannabinol: cannabidiol (THC: CBD)","volume":"19","author":"Meyer","year":"2019","journal-title":"BMC Neurol."},{"issue":"11","key":"10.1016\/j.mrrev.2024.108518_bib191","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-029449","article-title":"Study protocol for a randomised, double-blind, placebo-controlled study evaluating the Efficacy of cannabis-based Medicine Extract in slowing the disease pRogression of Amyotrophic Lateral sclerosis or motor neurone disease: the EMERALD trial","volume":"9","author":"Urbi","year":"2019","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.mrrev.2024.108518_bib192","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-064173","article-title":"Motor Neuron Disease Systematic Multi-Arm Adaptive Randomised Trial (MND-SMART): a multi-arm, multi-stage, adaptive, platform, phase III randomised, double-blind, placebo-controlled trial of repurposed drugs in motor neuron disease","volume":"12","author":"Wong","year":"2022","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.mrrev.2024.108518_bib193","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ng.2853","article-title":"Therapeutic modulation of eIF2\u03b1 phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models","volume":"46","author":"Kim","year":"2014","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.mrrev.2024.108518_bib194","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809423","article-title":"Repeat-associated non-AUG translation in C9orf72-ALS\/FTD is driven by neuronal excitation and stress","volume":"11","author":"Westergard","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.mrrev.2024.108518_bib195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-018-0288-y","article-title":"Progranulin reduces insoluble TDP-43 levels, slows down axonal degeneration and prolongs survival in mutant TDP-43 mice","volume":"13","author":"Beel","year":"2018","journal-title":"Mol. Neurodegener."},{"issue":"3","key":"10.1016\/j.mrrev.2024.108518_bib196","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/ana.25302","article-title":"Repeated intrathecal mesenchymal stem cells for amyotrophic lateral sclerosis","volume":"84","author":"Oh","year":"2018","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.mrrev.2024.108518_bib197","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3390\/ijms19030886","article-title":"The role of post-translational modifications on prion-like aggregation and liquid-phase separation of FUS","volume":"19","author":"Rhoads","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mrrev.2024.108518_bib198","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.trsl.2018.10.002","article-title":"Epigenetics in amyotrophic lateral sclerosis: a role for histone post-translational modifications in neurodegenerative disease","volume":"204","author":"Bennett","year":"2019","journal-title":"Transl. Res."},{"issue":"7","key":"10.1016\/j.mrrev.2024.108518_bib199","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020106177","article-title":"HDAC6 inhibition restores TDP-43 pathology and axonal transport defects in human motor neurons with TARDBP mutations","volume":"40","author":"Fazal","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.mrrev.2024.108518_bib200","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.00293","article-title":"ROCK-ALS: protocol for a randomized, placebo-controlled, double-blind phase IIa trial of safety, tolerability and efficacy of the rho kinase (ROCK) inhibitor fasudil in amyotrophic lateral sclerosis","volume":"10","author":"Lingor","year":"2019","journal-title":"Front. Neurol."},{"issue":"633","key":"10.1016\/j.mrrev.2024.108518_bib201","doi-asserted-by":"crossref","first-page":"eabj0264","DOI":"10.1126\/scitranslmed.abj0264","article-title":"Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS","volume":"14","author":"Hop","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"46","key":"10.1016\/j.mrrev.2024.108518_bib202","doi-asserted-by":"crossref","first-page":"16619","DOI":"10.1523\/JNEUROSCI.1639-11.2011","article-title":"Epigenetic regulation of motor neuron cell death through DNA methylation","volume":"31","author":"Chestnut","year":"2011","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.mrrev.2024.108518_bib203","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41419-019-1451-2","article-title":"Targeting the sigma-1 receptor via pridopidine ameliorates central features of ALS pathology in a SOD1G93A model","volume":"10","author":"Ionescu","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.mrrev.2024.108518_bib204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-018-0586-1","article-title":"Nuclear poly (ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis","volume":"6","author":"McGurk","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"issue":"4","key":"10.1016\/j.mrrev.2024.108518_bib205","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126942","article-title":"Emerging small-molecule therapeutic approaches for amyotrophic lateral sclerosis and frontotemporal dementia","volume":"30","author":"Brown","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.mrrev.2024.108518_bib206","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s13311-016-0499-2","article-title":"Withania somnifera reverses transactive response DNA binding protein 43 proteinopathy in a mouse model of amyotrophic lateral sclerosis\/frontotemporal lobar degeneration","volume":"14","author":"Dutta","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.mrrev.2024.108518_bib207","article-title":"Effect of Combined Intravenous Immunoglobulin and Classical Complement Inhibitor ANX005 in Guillain-Barr\u00e9 Syndrome (S25. 002)","author":"Harbo","year":"2022","journal-title":"AAN Enterp."},{"issue":"4","key":"10.1016\/j.mrrev.2024.108518_bib208","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/brain\/awg073","article-title":"Muscle cramp in Machado\u2013Joseph disease: altered motor axonal excitability properties and mexiletine treatment","volume":"126","author":"Kanai","year":"2003","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.mrrev.2024.108518_bib209","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/jamaneurol.2020.4300","article-title":"Effect of ezogabine on cortical and spinal motor neuron excitability in amyotrophic lateral sclerosis: a randomized clinical trial","volume":"78","author":"Wainger","year":"2021","journal-title":"JAMA Neurol."},{"issue":"21","key":"10.1016\/j.mrrev.2024.108518_bib210","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202200396","article-title":"Superoxide Dismutase 1 Folding Stability as a Target for Molecular Tweezers in SOD1-Related Amyotrophic Lateral Sclerosis","volume":"23","author":"Samanta","year":"2022","journal-title":"ChemBioChem"},{"issue":"4","key":"10.1016\/j.mrrev.2024.108518_bib211","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/ene.15237","article-title":"Urinary neopterin: a novel biomarker of disease progression in amyotrophic lateral sclerosis","volume":"29","author":"Shepheard","year":"2022","journal-title":"Eur. J. Neurol."},{"issue":"51","key":"10.1016\/j.mrrev.2024.108518_bib212","doi-asserted-by":"crossref","first-page":"16995","DOI":"10.1021\/acs.analchem.1c02546","article-title":"Tear-based vibrational spectroscopy applied to amyotrophic lateral sclerosis","volume":"93","author":"Ami","year":"2021","journal-title":"Anal. Chem."},{"issue":"8","key":"10.1016\/j.mrrev.2024.108518_bib213","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3390\/biomedicines9080969","article-title":"Mitogen-activated protein kinase pathway in amyotrophic lateral sclerosis","volume":"9","author":"Sahana","year":"2021","journal-title":"Biomedicines"},{"issue":"12","key":"10.1016\/j.mrrev.2024.108518_bib214","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.chembiol.2019.10.005","article-title":"Development of MAP4 kinase inhibitors as motor neuron-protecting agents","volume":"26","author":"Bos","year":"2019","journal-title":"Cell Chem. Biol."},{"issue":"4","key":"10.1016\/j.mrrev.2024.108518_bib215","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab242","article-title":"Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective","volume":"3","author":"Wong","year":"2021","journal-title":"Brain Commun."},{"key":"10.1016\/j.mrrev.2024.108518_bib216","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1153973","article-title":"\u201cHuoling Shengji granule\u201d for amyotrophic lateral sclerosis: protocol for a multicenter, randomized, double-blind, riluzole parallel controlled clinical trial","volume":"15","author":"Liu","year":"2023","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.mrrev.2024.108518_bib217","first-page":"1","article-title":"Fingerprint analysis of Huolingshengji Formula and its neuroprotective effects in SOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"8","author":"Zhou","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.mrrev.2024.108518_bib218","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/mus.27339","article-title":"Tocilizumab is safe and tolerable and reduces C-reactive protein concentrations in the plasma and cerebrospinal fluid of ALS patients.","volume":"64","author":"Milligan","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.mrrev.2024.108518_bib219","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.00173","article-title":"Compassionate use of the ROCK inhibitor fasudil in three patients with amyotrophic lateral sclerosis","volume":"11","author":"Koch","year":"2020","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.mrrev.2024.108518_bib220","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/jnnp-2018-319294","article-title":"Ultra-high-dose methylcobalamin in amyotrophic lateral sclerosis: a long-term phase II\/III randomised controlled study","volume":"90","author":"Kaji","year":"2019","journal-title":"J. Neurol., Neurosurg. Psychiatry"},{"issue":"8","key":"10.1016\/j.mrrev.2024.108518_bib221","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/13543784.2023.2252738","article-title":"CNM-Au8: an experimental agent for the treatment of amyotrophic lateral sclerosis (ALS)","volume":"32","author":"Bireley","year":"2023","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"3","key":"10.1016\/j.mrrev.2024.108518_bib222","article-title":"Randomized phase 2 trial of NP001, a novel immune regulator: safety and early efficacy in ALS","volume":"2","author":"Miller","year":"2015","journal-title":"Neuroimmunol. Neuroinflamm."}],"container-title":["Mutation Research - Reviews in Mutation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383574224000310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383574224000310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:31:27Z","timestamp":1778520687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383574224000310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":222,"alternative-id":["S1383574224000310"],"URL":"https:\/\/doi.org\/10.1016\/j.mrrev.2024.108518","relation":{},"ISSN":["1383-5742"],"issn-type":[{"value":"1383-5742","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unraveling the multifaceted insights into amyotrophic lateral sclerosis: Genetic underpinnings, pathogenesis, and therapeutic horizons","name":"articletitle","label":"Article Title"},{"value":"Mutation Research - Reviews in Mutation Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mrrev.2024.108518","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108518"}}